Vital Signs
  • Home
  • About
Sign in Subscribe

BioNTech

A collection of 5 posts
EMA recommends five new medicines, including a  first-in-class small interfering RNA treatment
EMA

EMA recommends five new medicines, including a first-in-class small interfering RNA treatment

Five new medicines are recommended for approval; a further nine medicines are recommended for extension of their therapeutic indications
26 Apr 2026 2 min read
Belgian court ruling triggers vaccine blame game in Poland and Romania
COVID-19

Belgian court ruling triggers vaccine blame game in Poland and Romania

A Brussels court rules both Poland and Romania must honour binding vaccine contracts signed during the pandemic
03 Apr 2026 3 min read
Inside EU Health: AMR pipeline; EU AI food safety tool; mRNA duo to found new company
Inside EU Health

Inside EU Health: AMR pipeline; EU AI food safety tool; mRNA duo to found new company

Report warns of 'worryingly thin' antimicrobial treatments pipeline; New EU AI tool aims to transform food crisis response; BioNTech co-founders will leave to focus on next-generation mRNA innovations
10 Mar 2026 3 min read
BioNTech co-founders leave to focus on next-generation mRNA innovation
mRNA

BioNTech co-founders leave to focus on next-generation mRNA innovation

Husband-and-wife team who transformed BioNTech into a global vaccine leader are leaving to pioneer the next wave of mRNA disruptors
10 Mar 2026 1 min read
Inside EU Health: Council position on Critical Medicines Act; UK-US deal will removes tariffs; will the GLP-1 manufacturers step up to WHO challenge
Inside EU Health

Inside EU Health: Council position on Critical Medicines Act; UK-US deal will removes tariffs; will the GLP-1 manufacturers step up to WHO challenge

Council reaches position on Critical Medicines Act; UK-US deal will increase the cost of drugs but removes tariffs; will the GLP-1 manufacturers step up to WHO challenge
03 Dec 2025 4 min read
Page 1 of 1
Vital Signs © 2026
  • Sign up
Powered by Ghost